Kawakami Mark
CIK 0002030709
Chief Financial Officer
Filings
4
Latest May 12, 2025
Issuers covered
1
Showing
4 of 4
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -15.1% | -15.1% | -7.5% | -22.6% |
| 90 days | 2 | 50% | +10.5% | +10.5% | +43.7% | -22.6% |
| 180 days | 2 | 50% | +30.3% | +30.3% | +73.8% | -13.2% |
| 365 days | 2 | 50% | -8.5% | -8.5% | +43.7% | -60.6% |
Issuers
Companies where Kawakami Mark has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RKDA | Arcadia Biosciences, Inc. | 4 | May 12, 2025 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|